StockData
Greenwich LifeSciences, Inc. logo

Greenwich LifeSciences, Inc. (GLSI) stock

GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 6/30
$18.70+4.94 (+35.90%)

Close on Nov 17, 2026Market cap $274.48MP/E –Yield –

Greenwich LifeSciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Greenwich LifeSciences's price to book ratio was 75.8× on Nov 11, 2026, against 255.9× a year earlier. Over the last 5 years it ranged from 5.1× to 255.9×, with a median of 17.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202675.8×−56.9
2025Dec 31, 2025132.6×+103.0
2024Dec 31, 202429.6×+14.4
2023Dec 29, 202315.3×+2.6
2022Dec 30, 202212.7×+1.6
2021Dec 31, 202111.1×−82.6
2020Dec 31, 202093.7×–

More Greenwich LifeSciences figures

See a number that looks wrong?